• Poster

Lapatinib Monotherapy in HER2+ Relapsed or Refractory Infl ammatory Breast Cancer (IBC): Quality of Life (QOL) Assessment

Citation

Kaufman, B., Bachelot, T., Wu, Y., Amonkar, M., zaks, t., Salazar, V., ... Johnston, S. (2008, December). Lapatinib Monotherapy in HER2+ Relapsed or Refractory Infl ammatory Breast Cancer (IBC): Quality of Life (QOL) Assessment. Presented at 2008 San Antonio Breast Cancer Symposium (SABCS), .

Abstract